Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.050
+0.020 (0.99%)
Apr 7, 2026, 4:11 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 384.38 million as of April 7, 2026. Its market cap has decreased by -35.06% in one year.
Market Cap
384.38M
Enterprise Value
676.83M
Revenue
737.49M
Ranking
n/a
PE Ratio
14.54
Stock Price
2.05
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 384.38M, a decrease of -44.31%. That is a compound annual growth rate of -11.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 384.38M | -26.78% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.87B |
| Integral Diagnostics | 837.78M |
| Healius | 377.59M |
| Monash IVF Group | 257.16M |
| Rhythm Biosciences | 63.66M |
| Cryosite | 53.45M |
| INOVIQ | 48.57M |
| Microba Life Sciences | 41.41M |